Farallon Capital Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.22M | Sell |
|
|||||
|
2025
Q1 | $8.69M | Hold |
|
|||||
|
2024
Q4 | $14.6M | Buy |
|
|||||
|
2024
Q3 | $13.4M | Hold |
|
|||||
|
2024
Q2 | $18.1M | Hold |
|
|||||
|
2024
Q1 | $21.3M | Buy |
|
|||||
|
2023
Q4 | $10.9M | Hold |
|
|||||
|
2023
Q3 | $10M | Hold |
|
|||||
|
2023
Q2 | $14.8M | Buy |
|
|||||
|
2023
Q1 | $6.14M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $20.4M | Sell |
|
|||||
|
2019
Q1 | $19.1M | Buy |
|
|||||
|
2018
Q4 | $8.55M | Hold |
|
|||||
|
2018
Q3 | $17.2M | Buy |
|
|||||
|
2018
Q2 | $15M | Sell |
|
|||||
|
2018
Q1 | $16.7M | Buy |
|
|||||
|
2017
Q4 | $10.9M | Buy |
|
|||||
|
2017
Q3 | $3.45M | Buy |
|